Literature DB >> 23584730

Laser treatment of recurrent herpes labialis: a literature review.

Carlos de Paula Eduardo1, Ana Cecilia Corrêa Aranha, Alyne Simões, Marina Stella Bello-Silva, Karen Muller Ramalho, Marcella Esteves-Oliveira, Patrícia Moreira de Freitas, Juliana Marotti, Jan Tunér.   

Abstract

Recurrent herpes labialis is a worldwide life-long oral health problem that remains unsolved. It affects approximately one third of the world population and causes frequent pain and discomfort episodes, as well as social restriction due to its compromise of esthetic features. In addition, the available antiviral drugs have not been successful in completely eliminating the virus and its recurrence. Currently, different kinds of laser treatment and different protocols have been proposed for the management of recurrent herpes labialis. Therefore, the aim of the present article was to review the literature regarding the effects of laser irradiation on recurrent herpes labialis and to identify the indications and most successful clinical protocols. The literature was searched with the aim of identifying the effects on healing time, pain relief, duration of viral shedding, viral inactivation, and interval of recurrence. According to the literature, none of the laser treatment modalities is able to completely eliminate the virus and its recurrence. However, laser phototherapy appears to strongly decrease pain and the interval of recurrences without causing any side effects. Photodynamic therapy can be helpful in reducing viral titer in the vesicle phase, and high-power lasers may be useful to drain vesicles. The main advantages of the laser treatment appear to be the absence of side effects and drug interactions, which are especially helpful for older and immunocompromised patients. Although these results indicate a potential beneficial use for lasers in the management of recurrent herpes labialis, they are based on limited published clinical trials and case reports. The literature still lacks double-blind controlled clinical trials verifying these effects and such trials should be the focus of future research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23584730     DOI: 10.1007/s10103-013-1311-8

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  99 in total

Review 1.  The history of photodetection and photodynamic therapy.

Authors:  R Ackroyd; C Kelty; N Brown; M Reed
Journal:  Photochem Photobiol       Date:  2001-11       Impact factor: 3.421

2.  830 nm laser irradiation induces varicosity formation, reduces mitochondrial membrane potential and blocks fast axonal flow in small and medium diameter rat dorsal root ganglion neurons: implications for the analgesic effects of 830 nm laser.

Authors:  Roberta T Chow; Monique A David; Patricia J Armati
Journal:  J Peripher Nerv Syst       Date:  2007-03       Impact factor: 3.494

Review 3.  Treatment and prevention of herpes labialis.

Authors:  Wim Opstelten; Arie Knuistingh Neven; Just Eekhof
Journal:  Can Fam Physician       Date:  2008-12       Impact factor: 3.275

4.  Low-level-laser therapy as an alternative treatment for primary herpes simplex infection: a case report.

Authors:  Ricardo Navarro; Marcela Marquezan; Daniella Ferraz Cerqueira; Bruno Lopes D A Silveira; Maria Salete Nahás Pires Corrêa
Journal:  J Clin Pediatr Dent       Date:  2007       Impact factor: 1.065

Review 5.  5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.

Authors:  Q Peng; T Warloe; K Berg; J Moan; M Kongshaug; K E Giercksky; J M Nesland
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

6.  Mechanisms of photodynamic inactivation of herpes simplex viruses: comparison between methylene blue, light plus electricity, and hematoporhyrin plus light.

Authors:  L E Schnipper; A A Lewin; M Swartz; C S Crumpacker
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

7.  The effect of 670-nm low laser therapy on herpes simplex type 1.

Authors:  Pedro Jose Muñoz Sanchez; José Luis Capote Femenías; Alejandro Díaz Tejeda; Jan Tunér
Journal:  Photomed Laser Surg       Date:  2011-11-02       Impact factor: 2.796

Review 8.  Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.

Authors:  P G Arduino; S R Porter
Journal:  Oral Dis       Date:  2006-05       Impact factor: 3.511

Review 9.  Prevention of ulcerative lesions by episodic treatment of recurrent herpes labialis: A literature review.

Authors:  Johan Harmenberg; Bo Oberg; Spotwood Spruance
Journal:  Acta Derm Venereol       Date:  2010-03       Impact factor: 4.437

10.  Inactivation of viruses by chemically and photochemically generated singlet molecular oxygen.

Authors:  K Müller-Breitkreutz; H Mohr; K Briviba; H Sies
Journal:  J Photochem Photobiol B       Date:  1995-09       Impact factor: 6.252

View more
  4 in total

Review 1.  Efficacy of low-level laser therapy in management of recurrent herpes labialis: a systematic review.

Authors:  Sadeq Ali Al-Maweri; Butchibabu Kalakonda; Nader Ahmed AlAizari; Walid A Al-Soneidar; Sajna Ashraf; Saleem Abdulrab; Eman Saleh Al-Mawri
Journal:  Lasers Med Sci       Date:  2018-05-25       Impact factor: 3.161

2.  Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy treatment for head and neck squamous cell carcinoma.

Authors:  Michelle Palmieri; Victor Adriano de Oliveira Martins; Laura Masami Sumita; Tania Regina Tozetto-Mendoza; Bruna Baraldi Romano; Clarisse Martins Machado; Claudio Sergio Pannuti; Thaís Bianca Brandão; Ana Carolina Prado Ribeiro; Luciana Corrêa; Paulo Henrique Braz-Silva
Journal:  Clin Oral Investig       Date:  2016-12-14       Impact factor: 3.573

3.  Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy for head and neck squamous cell carcinoma is not affected by xerostomia.

Authors:  Michelle Palmieri; Mariana Ornaghi; Victor Adriano de Oliveira Martins; Luciana Correa; Thais Bianca Brandao; Ana Carolina do Prado Ribeiro; Laura Masami Sumita; Tania Regina Tozetto-Mendoza; Claudio Sergio Pannuti; Paulo Henrique Braz-Silva
Journal:  J Oral Microbiol       Date:  2018-05-28       Impact factor: 5.474

4.  Blue Laser Light Counteracts HSV-1 in the SH-SY5Y Neuronal Cell Model of Infection.

Authors:  Luisa Zupin; Sergio Crovella
Journal:  Life (Basel)       Date:  2022-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.